<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>448</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15627976</PubmedId>
            <Abstract>Although early studies have shown a close correlation between epitope density and epitope-specific humoral immune responses, few attempts have been made to quantitatively compare the antigenic and immunogenic differences between protein molecules bearing low or high degrees of epitope density, nor have studies quantitatively investigated the mechanism of B cell discrimination of monomeric antigens. In this study, we prepared glutathione S-transferase (GST) fusion proteins bearing various copies of the M2e epitope from the influenza virus M2 protein [GST-(M2e)8, GST-(M2e)4 and GST-(M2e)1], which were used to detect and compare the real-time kinetic binding with M2e-specific mAb by surface plasma resonance. Our data show clearly that fusion proteins bearing higher M2e epitope density resulted in higher average avidity for M2e-specific mAb. Furthermore, it was observed that fusion proteins bearing high M2e epitope density could induce polyclonal antibodies (pAb) with enhanced an average affinity constant (KA) for M2e epitope peptide compared to fusion proteins bearing low epitope density. The average KA of pAb induced by GST-(M2e)8 (3.08 x 10(8) M(-1) or 9.96 x 10(8) M(-1)) was up to two orders of magnitude greater than the average KA of pAb induced by GST-(M2e)1 (2.00 x 10(6) M(-1) or 3.43 x 10(6) M(-1)). Thus, the data presented here demonstrate that high epitope density in a single protein molecule significantly enhances antigenicity and immunogenicity. These findings enrich our knowledge of how epitope density might relate to the recognition, activation and antibody production processes of epitope-specific immature B cells.</Abstract>
            <ArticleYear>2005</ArticleYear>
            <ArticlePages>505-14</ArticlePages>
            <ArticleTitle>High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Wanli</ForeName>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Ying-Hua</ForeName>
                </Author>
            </Authors>
            <Affiliations>Laboratory of Immunology, Department of Biology and Institute of Biomedical Science, Tsinghua University, Protein Science Laboratory of the MOE, Beijing, PR China.</Affiliations>
            <ArticleChemicalList>Antibodies, Monoclonal;Antigens;Epitopes;Proteins;Recombinant Fusion Proteins;Vaccines;Glutathione Transferase</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Antibodies, Monoclonal(immunology); Antigens(immunology); B-Lymphocytes(immunology); Enzyme-Linked Immunosorbent Assay; Epitopes(immunology); Glutathione Transferase(genetics; immunology; metabolism); Kinetics; Orthomyxoviridae(immunology); Protein Binding; Proteins(immunology); Rabbits; Recombinant Fusion Proteins(genetics; immunology; metabolism); Surface Plasmon Resonance; Time Factors; Vaccines(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>35</Volume>
                <Issue>2</Issue>
                <Title>European journal of immunology</Title>
                <Issn>0014-2980</Issn>
                <MedlineTa>Eur J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>M2e</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                        <StartingPosition>2</StartingPosition>
                        <EndingPosition>24</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA30889.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Materials and Methods</LocationOfData>
                <EpitopeId>59318</EpitopeId>
                <ReferenceStartingPosition>2</ReferenceStartingPosition>
                <ReferenceEndingPosition>24</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1 and figure 1</LocationOfData>
                        <BCellId>2117</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA30889.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>P0A9D2.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>83333</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The preparation and characterization of the mAb was described previously Liu et al. Immunol. Lett. 2004. 93:131-136 [15158608].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>159</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope-specific mAb bound GST-fusion proteins expressing different epitope densities (repetitions of 1, 4 or 8 peptides). Constructs containing higher M2e epitope density resulted in higher average avidity for M2e-specific mAb. The epitope contained an additional N-terminal K residue.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>8C6</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>(M2e 2-24)&lt;sub&gt;8&lt;/sub&gt;</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                        <StartingPosition>2</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA30889.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11320</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Peptide Repeat Sequence (linear)</ComplexType>
                                    <PeptideModifications/>
                                    <SourceMolecule>
                                        <GenBankId>P0A9D2.1</GenBankId>
                                    </SourceMolecule>
                                    <MoleculeSourceOrganismId>83333</MoleculeSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Tables 2 and 3 and Figure 3</LocationOfData>
                        <BCellId>16285</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>2</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>CAA30889.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>(M2e 1-24)&lt;sub&gt;8&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide Repeat Sequence (linear)</ComplexType>
                                        <PeptideSequence>SLLTEVETPIRNEWGCRCNDSSD</PeptideSequence>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>P0A9D2.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>83333</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 200 µg, administered on days 1, 23, and 45.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen was constructed as a fusion protein harboring 8 copies of the epitope fused to GST. Also constructs with 1 and 4 repetitions were tested. The immunogen was given in an unspecified adjuvant. Antisera were collected on day 75.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>242</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.308</QuantitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>GST-epitope&lt;sub&gt;8&lt;/sub&gt; induced K&lt;sub&gt;A&lt;/sub&gt; values were up to two orders of magnitude greater than the average K&lt;sub&gt;A&lt;/sub&gt; of pAb induced by GST-epitope&lt;sub&gt;1&lt;/sub&gt;.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>M2e</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                        <StartingPosition>2</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA30889.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11320</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>2125</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                            <StartingPosition>2</StartingPosition>
                                            <EndingPosition>24</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>CAA30889.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11320</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>(M2e 1-24)&lt;sub&gt;8&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide Repeat Sequence (linear)</ComplexType>
                                        <PeptideSequence>SLLTEVETPIRNEWGCRCNDSSD</PeptideSequence>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>P0A9D2.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>83333</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 doses of 200 µg, administered on days 1, 23, and 45.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen was constructed as a fusion protein harboring 8 copies of the epitope fused to GST. Also constructs with 1 and 4 repetitions were tested. The immunogen was given in an unspecified adjuvant. Antisera were collected on day 75.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Antigen binding by pAb increases with the increase of the immunogen polymer length. The epitope contained an additional N-terminal K residue.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>M2e</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SLLTEVETPIRNEWGCRCNDSSD</LinearSequence>
                                        <StartingPosition>2</StartingPosition>
                                        <EndingPosition>24</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA30889.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11320</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

